Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | LSS | P48449 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.41 |
| ▸ | SQLE | Q14534 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL846760 | 1.00 | TSHR (0.50) | TSHRLSSKMT2AALOX15MAPT | |
| SCHEMBL847887 | 0.86 | TSHR (0.54) | TSHRLSSKMT2AALOX15MAPT | |
| SCHEMBL847994 | 0.86 | TSHR (0.48) | TSHRLSSKMT2AALOX15MAPT | |
| SCHEMBL847993 | 0.86 | TSHR (0.48) | TSHRLSSKMT2AALOX15MAPT | |
| SCHEMBL847886 | 0.86 | TSHR (0.54) | TSHRLSSKMT2AALOX15MAPT | |
| SCHEMBL8669621 | 0.85 | LSS (0.58) | LSSKMT2AALOX15MAPTALDH1A1 | |
| SCHEMBL8669624 | 0.85 | LSS (0.58) | LSSKMT2AALOX15MAPTALDH1A1 | |
| SCHEMBL544038 | 0.83 | — | — | |
| SCHEMBL847591 | 0.83 | — | — | |
| SCHEMBL846896 | 0.81 | KMT2A (0.46) | TSHRLSSKMT2AALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882283-A1 | ETHYLENE-COPOLYMERS AND CATALYST MIXTURE FOR MAKING ETHYLENE COPOLYMERS | Arlanxeo Netherlands B.V. (NL) | 2021-09-22 | — | — | EP | claimed |
| US-9382344-B2 | Mitigation of catalyst inhibition in olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-07-05 | — | — | US | claimed |
| EP-3013867-A1 | MITIGATION OF CATALYST INHIBITION IN OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2016-05-04 | — | — | EP | claimed |
| WO-2014209813-A1 | MITIGATION OF CATALYST INHIBITION IN OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-12-31 | — | — | WO | claimed |
| US-20140378732-A1 | Mitigation of Catalyst Inhibition in Olefin Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-12-25 | — | — | US | claimed |
| EP-1016689-B1 | Olefin thermoplastic elastomer compositions | MITSUI CHEMICALS INC (JP) | 2007-03-07 | — | — | EP | claimed |
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | ARLANXEO NETHERLANDS B.V. (NL) | 2026-02-24 | — | — | US | disclosed |
| US-20250313041-A1 | TIRE COMPOSITIONS COMPRISING FUNCTIONALIZED RUBBERS BASED ON ETHYLENE-COPOLYMERS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-10-09 | — | — | US | disclosed |
| EP-4043500-B1 | ETHYLENE·ALPHA-OLEFIN·NON-CONJUGATED POLYENE COPOLYMER, USE THEREOF, AND MANUFACTURING METHOD THEREOF | MITSUI CHEMICALS INC (JP) | 2025-08-13 | — | — | EP | disclosed |
| EP-4330297-B1 | METAL COMPLEX CATALYST FOR THE POLYMERIZATION OF OLEFINS | Arlanxeo Netherlands Bv (NL) | 2025-07-30 | — | — | EP | disclosed |
| US-20250215118-A1 | PROCESS FOR PRODUCING POLYMERS | ARLANXEO NETHERLANDS B.V. (NL) | 2025-07-03 | — | — | US | disclosed |
| CN-119841997-A | Process for preparing ethylene copolymers | 阿朗新科高性能弹性体(常州)有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-2747150-B1 | SOLAR CELL SEALING MATERIAL, METHOD FOR MANUFACTURING SOLAR CELL SEALING MATERIAL, AND SOLAR CELL MODULE | MITSUI CHEMICALS ICT MATERIA INC (JP) | 2024-12-18 | — | — | EP | disclosed |
| US-5387664-A | Heat and aging resistance | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-02-07 | — | — | US | disclosed |
| EP-0634427-A1 | Higher alpha-olefin copolymer, process for the preparation of the same, rubber composition comprising the same, and rubber molded product comprising the same | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-18 | — | — | EP | disclosed |
| US-5349020-A | Olefin-diene copolymer and a second rubber | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-20 | — | — | US | disclosed |
| EP-0559218-A1 | Vulcanizable rubber composition | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1993-09-08 | — | — | EP | disclosed |
| EP-0552798-A2 | Higher alpha-olefin copolymer, process for the preparation of the same, vibration insulating rubber molded product, and process for the preparation of the rubber molded product | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-5229463-A | Blending, crosslinking propylene copolymerized with conjugated and non-connugated dienes, EPDM rubber and crystalline propylene polymer | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1993-07-20 | — | — | US | disclosed |
| EP-0486293-A2 | Thermoplastic resin compositions having improved strength and method for producing them | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | EEF1D, COG7, CCND1 | TSHR 3104/4885LSS 1507/4885KMT2A 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.